Skip to content
Sign in
AcceleratorBacked 1 network startup

Octane LaunchPad

US accelerator with no profile in our data; supported maternal-health medtech Lidavex.

United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
1most often with Gust Accelerator

How they invest

Unknown; one medtech support.

Stage and ticket

Accelerator/support.

Geography

United States (HQ).

What makes them say yes

  • Early medtech (inferred)
  • US
  • Accelerator readiness

Red flags

  • No published thesis, ticket or stage policy in our data — any approach is a cold qualification call
  • Pitching outside the single sector signal visible in its known deal

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask Lidavex for programme details.

Portfolio

1 network startup · no other company

Lidavex alongside Gust Accelerator.

Gaps in the portfolio

  • Unknown thesis

Network startups

  • LidavexSWC 2026 Finalist

    Maternal-health device start-up using LiDAR to measure cervical dilation in labour and build a cervical data infrastructure for AI.

    United States · MedTech & devices

    • Accelerators / support programsSource

Network startups that fit

3 analysed

Nurse-practitioner-founded device start-up designing a multi-drug emergency IV pump with protocol-guided dosing safeguards.

US emergency IV pump.

30%confidence

Evidence from the records

  • “Lidavex”
  • “Multi-drug emergency IV pump”
  • “No public evidence of traction found: pump shown as a concept visual”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Octane LaunchPad).
First step
Ask Lidavex.

FDA-cleared low-cost automated peritoneal dialysis cycler, built in a DRAP-approved Pakistani factory, preparing first US patients.

US home dialysis at seed.

25%confidence

Evidence from the records

  • “Lidavex”
  • “At-home peritoneal dialysis”
  • “X-1 APD cycler and DS-1 set: FDA 510(k) clearance K243371 (decision of 16 May 2025, class II)”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Octane LaunchPad).
First step
Ask Lidavex.

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

US self-injection devices.

25%confidence

Evidence from the records

  • “Lidavex”
  • “Self-injection devices”
  • “UniPen available through licensed pharmacies (not FDA-authorized)”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Octane LaunchPad).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Gust Accelerator

Sources

  1. 1pitchbook.com/profiles/company/600846-40
  2. 2cityofirvine.gov/node/90666

Profile compiled from public sources. Unknown fields are left empty rather than estimated.